ADMA Biologics Inc vs iShares Russell 2000 ETF — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while iShares Russell 2000 ETF trades at $301.52. The key difference: iShares Russell 2000 ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | IWM | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | — |
52-Week High | $20.38 | $301.69 |
52-Week Low | $7.60 | $225.45 |
Enterprise Value | $2.29B | — |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →